START (Siddha Treatment Accelerating Recovery from SARS-CoV-2 Test) trial of Siddha treatment for patients with novel coronavirus infectious disease (COVID-19)

2020 ◽  
Author(s):  
Gopalakrishnan Thanicakachalam
Keyword(s):  
Infectious Disease ◽  
Test Trial ◽  
Novel Coronavirus

Indian Lifestyle With Ayurveda Perspective During Covid-19 Pandemic

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1396-1399
Author(s):  
Disha Bhatero ◽  
Punam Sawarkar ◽  
Gaurav Sawarkar
Keyword(s):  
Infectious Disease ◽  
Disease Resistance ◽  
Prevalence Rate ◽  
Code Of Conduct ◽  
Google Scholar ◽  
Research Articles ◽  
Narrative Form ◽  
Healthy Individuals ◽  
Novel Coronavirus

Covid-19 is an infectious disease caused by novel Coronavirus. The overall prevalence rate of Covid-19 in Worldwide ( 9.94M )& it is (529 K) & (153 K) in India and Maharashtra. This situation can be considered under JanapadodhwansaVyadhi in Ayurveda. The primary purpose of Ayurveda  is the prevention of the disease in healthy individuals and eradication of disease, which are curable. Immunity comes under the Vyadhikshamatva. Further, Covid-19 infection is correlated with Vataj-Kaphaj Jwara. In Ayurveda Rasayana therapy to boost up immunity (Bala  & Vyadhikshamatva). The present study aimed to explore the concept of infectious disease and its prevention through different lifestyles described in Ayurveda. The above need-based information is collected from various Ayurvedicliterature (Laghutrayee, Bruhatryayi) along with numerous research articles from databases, such as PubMed, Google Scholar. All collected data were depicted in narrative form and tabular manner under different heads. Considering the above aspect in the prevention of Covid-19, the role of Ayurveda intervention may be proved more beneficial in Covid-19. Further, adoption of code of conduct may efficiently overcome the current pandemic situation by maintaining good immunity & implementation of Ahar, Vihar Vidhis, Dincharya, and Rutucharya& Sadvritta  for improving disease resistance.

scholarly journals Time Course of COVID-19 Cases in Austria

2020 ◽  
Vol 17 (9) ◽  
pp. 3270 ◽  
Author(s):  
Hanns Moshammer ◽  
Michael Poteser ◽  
Kathrin Lemmerer ◽  
Peter Wallner ◽  
Hans-Peter Hutter
Keyword(s):  
Public Health ◽  
Infectious Disease ◽  
Time Course ◽  
Reproduction Number ◽  
Average Duration ◽  
Northern Italy ◽  
Reproduction Rate ◽  
Health Measures ◽  
Major Outbreak ◽  
Novel Coronavirus

COVID-19 is an infectious disease caused by a novel coronavirus, which first appeared in China in late 2019, and reached pandemic distribution in early 2020. The first major outbreak in Europe occurred in Northern Italy where it spread to neighboring countries, notably to Austria, where skiing resorts served as a main transmission hub. Soon, the Austrian government introduced strict measures to curb the spread of the virus. Using publicly available data, we assessed the efficiency of the governmental measures. We assumed an average incubation period of one week and an average duration of infectivity of 10 days. One week after the introduction of strict measures, the increase in daily new cases was reversed, and the reproduction number dropped. The crude estimates tended to overestimate the reproduction rate in the early phase. Publicly available data provide a first estimate about the effectiveness of public health measures. However, more data are needed for an unbiased assessment.

scholarly journals Vertical Transmission

2020 ◽  
Vol 41 (1) ◽  
pp. 2
Author(s):  
Dena Lyras
Keyword(s):  
Public Health ◽  
Infectious Disease ◽  
Vertical Transmission ◽  
Racial Groups ◽  
The Novel ◽  
Local Part ◽  
Rapid Dissemination ◽  
Novel Coronavirus ◽  
The Impact

As we begin 2020, Microbiology is dominating the news with the emergence and rapid dissemination of the novel coronavirus COVID-19. The impact of COVID-19 on public health, with significant financial, logistical and social repercussions, has quickly become apparent. As microbiologists we have an important role to play during this time because we can use our knowledge, expertise and experience to educate the community around us, and to reduce the panic that results from fear and misinformation. It is also critical that we ensure that racial groups are not stigmatised because of an infectious disease. A co-ordinated global effort is required to tackle this new infectious threat, and we are an important local part of this effort. It is also important to develop strategies that can be deployed when the next threat emerges, as it surely will.

scholarly journals On a new conceptual mathematical model dealing the current novel coronavirus-19 infectious disease

2020 ◽  
Vol 19 ◽  
pp. 103510
Author(s):  
Anwarud Din ◽  
Kamal Shah ◽  
Aly Seadawy ◽  
Hussam Alrabaiah ◽  
Dumitru Baleanu
Keyword(s):  
Infectious Disease ◽  
Mathematical Model ◽  
Novel Coronavirus

scholarly journals A Late COVID-19 Complication: Male Sexual Dysfunction

2020 ◽  
Vol 35 (6) ◽  
pp. 688-689
Author(s):  
Saeed Shoar ◽  
Siamak Khavandi ◽  
Elsa Tabibzadeh ◽  
Aydin Vaez ◽  
Ali Khabbazi Oskouei ◽  
...  
Keyword(s):  
Infectious Disease ◽  
Sexual Dysfunction ◽  
Clinical Course ◽  
Urogenital System ◽  
Multiple Organs ◽  
Clinical Presentations ◽  
Male Sexual Dysfunction ◽  
Male Patients ◽  
Novel Coronavirus

AbstractSince the beginning of the coronavirus infectious disease 2019 (COVID-19) pandemic, an exponentially large amount of data has been published to describe the pathology, clinical presentations, and outcomes in patients infected with the severe acute respiratory syndrome novel coronavirus 2 (SARS-CoV-2). Although COVID-19 has been shown to cause a systemic inflammation predisposing the involvement of multiple organs, its mechanism affecting the urogenital system has not been well-documented. This case report presents the clinical course of two male patients with COVID-19 who developed sexual dysfunction, as anorgasmia, following recovery from the infection. Although no evidence of viral replication or inflammatory involvement could be identified in these cases’ urogenital organs, a lack of other known risk factors for anorgasmia points to the role of COVID-19 as the contributing factor.

scholarly journals Epidemiological description and analysis of RdRp, E and N genes dynamic by RT-PCR of SARS-CoV-2 in Moroccan population: Experience of the National Reference Laboratory (LNR)-UM6SS

2020 ◽  
Author(s):  
Houda Benrahma ◽  
Diawara Idrissa ◽  
Smyej Imane ◽  
Rahoui Jalila ◽  
Meskaouni Nida ◽  
...  
Keyword(s):  
Infectious Disease ◽  
Therapeutic Vaccine ◽  
Reference Laboratory ◽  
National Reference Laboratory ◽  
Rt Pcr ◽  
National Reference ◽  
Median Period ◽  
Epidemiological Profile ◽  
Novel Coronavirus ◽  
Positive Results

AbstractThe coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a new infectious disease that first emerged in Hubei province, China, in December 2019. On 2 March 2020, the Moroccan Ministry of Health confirmed the first COVID-19 case in Morocco. The new virus SARS-CoV-2 was identified in the sample of a Moroccan expatriate residing in Italy. Without a therapeutic vaccine or specific antiviral drugs, early detection and isolation become essential against novel Coronavirus.This study aims to analyze the epidemiological profile of the SARS-CoV-2 in Moroccan cases and to investigate the dynamic of RdRp, N, and E genes in patients from diagnosis until the recovery.Among 859 COVID-19 RT-PCR tests realized for 376 patients, 187 cases had positive results COVID-19. 4% were positive with the 3 genes RdRp, N, and E, 40 % with N and E genes, 3% with RdRp and N genes, 31% with only the RdRp gene and 22% cases are positives with N gene. The analysis of the Covid-19 genes (RdRp, N, and E) dynamic reveal that more than 6% stay positive with detection of the N and E gene, and 14% with the N gene after 12 days of treatment.The median period from positive to the first negative Covid-19 RT-PCR tests was 6.8±2.24 days for 44% cases, 14.31± 2.4 days for 30%, and 22.67 ± 1.21 days for 4%.This a first description of the Moroccan COVID-19 cases and the analysis of the dynamic of the RdRp, N, and E genes. The analysis of our population can help to improve in the care of patients.

scholarly journals Facemask shortage and the coronavirus disease (COVID-19) outbreak: Reflection on public health measures

2020 ◽  
Author(s):  
Huailiang Wu ◽  
Jian Huang ◽  
Casper J. P. Zhang ◽  
Zonglin He ◽  
Wai-Kit Ming
Keyword(s):  
Public Health ◽  
Infectious Disease ◽  
Disease Outbreaks ◽  
Wuhan City ◽  
Medical Resources ◽  
Infectious Disease Outbreaks ◽  
Health Measures ◽  
Global Pandemic ◽  
Novel Coronavirus ◽  
Effective Public Health

AbstractBackgroundA novel coronavirus disease (COVID-19) outbreak due to SARS-CoV-2 infection occurred in China in late-December 2019. Facemask wearing is considered as one of the most cost-effective and important measures to prevent the transmission of SARS-CoV-2, but it became a social concern due to the recent global facemask shortage. China is the major facemask producer in the world, contributing to 50% of global production. However, even full productivity (20 million facemasks per day) does not seem to meet the need of a population of 1.4 billion in China.MethodsPolicy review using government websites and shortage analysis using mathematical modelling based on data obtained from the National Health Commission (NHC), the Ministry of Industry and Information Technology (MIIT), the Center for Disease Control and Prevention (CDC) of the People’s Republic of China, and Wuhan Bureau of Statistics.FindingsSupplies of facemasks in the whole of China would have been sufficient for both healthcare workers and the general population if the COVID-19 outbreak only occurred in Wuhan city or Hubei province. However, if the outbreak occurred in the whole of China, facemask supplies in China could last for 5 days if under the existing public health measures and a shortage of 853 million facemasks is expected by 30 Apr 2020. Assuming a gradually decreased import volume, we estimated that dramatic increase in productivity (42.7 times of the usual level) is needed to mitigate the facemask crisis by the end of April.InterpretationIn light of the COVID-19 outbreak in China, a shortage of facemasks and other medical resources can considerably compromise the efficacy of public health measures. Effective public health measures should also consider the adequacy and affordability of medical resources. Global collaboration should be strengthened to prevent the development of a global pandemic from a regional epidemic via easing the medical resources crisis in the affected countries.Research in contextEvidence before this studyWe searched PubMed and Web of Science for articles in English, between 1 Jan 1980, and 1 Jan 2020, using the search terms 1) (infection OR infectious disease* OR outbreaks) AND (modelling); and 2) (mask* OR facemask* OR medical resource*) AND (infection OR infectious disease* OR outbreaks). Most relevant studies identified were performed to predict diseases spread and to determine the original infection source of previous epidemics like SARS and H7N9. However, few studies focused on the medical resources crisis during the outbreaks.Added value of this studyTo the best of our knowledge, this is the first study to investigate the facemask shortage during the novel coronavirus pneumonia (COVID-19) outbreak in China. We have summarized in detail the management strategies implemented by the Chinese governments during the outbreaks. By considering three scenarios for the outbreak development, we simulated the facemasks availability from late-December 2019 to late-April 2020 and estimated the duration of sufficient facemask supplies. Our findings showed that if the COVID-19 outbreak occurred only in Wuhan city or Hubei province, facemask shortage would not appear with the existing public health measures. However, if the outbreak occurred in the whole of China, a shortage of facemask could be substantial assuming no alternative public health measures.Implications of all the available evidenceOur findings provide insight into the public health measures to confront medical resources crisis during infectious disease outbreaks. Effective public health measures should consider the adequacy and affordability of existing medical resources. Governments across the world should revisit their emergency plans for controlling infectious disease outbreaks by taking into account the supply of and demand for the medical resource. Global collaboration should be strengthened to prevent the development of a global pandemic from a regional epidemic via easing the medical resources crisis in the affected countries.

scholarly journals Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives

Nanomedicine ◽  
2021 ◽  
Vol 16 (6) ◽  
pp. 497-516
Author(s):  
Hamid Rashidzadeh ◽  
Hossein Danafar ◽  
Hossein Rahimi ◽  
Faezeh Mozafari ◽  
Marziyeh Salehiabar ◽  
...  
Keyword(s):  
Infectious Disease ◽  
Therapeutic Agents ◽  
Rapid Diagnosis ◽  
Socioeconomic Impact ◽  
The Novel ◽  
Future Perspectives ◽  
Mortality And Morbidity ◽  
Self Assembling ◽  
Novel Coronavirus ◽  
Significant Mortality

COVID-19, as an emerging infectious disease, has caused significant mortality and morbidity along with socioeconomic impact. No effective treatment or vaccine has been approved yet for this pandemic disease. Cutting-edge tools, especially nanotechnology, should be strongly considered to tackle this virus. This review aims to propose several strategies to design and fabricate effective diagnostic and therapeutic agents against COVID-19 by the aid of nanotechnology. Polymeric, inorganic self-assembling materials and peptide-based nanoparticles are promising tools for battling COVID-19 as well as its rapid diagnosis. This review summarizes all of the exciting advances nanomaterials are making toward COVID-19 prevention, diagnosis and therapy.

scholarly journals Thinking Too Much About the Novel Coronavirus. The Link Between Persistent Thinking About COVID-19, SARS-CoV-2 Anxiety and Trauma Effects

2020 ◽  
Author(s):  
Sebastian Skalski ◽  
Patrycja Uram ◽  
Paweł Dobrakowski ◽  
Anna Kwiatkowska
Keyword(s):  
Mental Health ◽  
Infectious Disease ◽  
Regression Analysis ◽  
Psychometric Properties ◽  
Short Form ◽  
Anxiety Scale ◽  
The Novel ◽  
Mental Functioning ◽  
Novel Coronavirus ◽  
Polish Adaptation

Background. Earlier reports have shown that anxiety over the novel coronavirus may predict mental functioning during the pandemic. The objective of this study was to assess the links between persistent thinking about COVID-19, anxiety over SARS-CoV-2 and trauma effects. For the purpose of this study, the Polish adaptation of the Obsession with COVID-19 Scale (OCS) was implemented. Participants and procedure. The study involved 356 individuals aged 18–78 (58% females). In addition to OCS, the participants completed the following questionnaires: the Coronavirus Anxiety Scale and the Short Form of the Changes in Outlook Questionnaire. Results. OCS was characterized by satisfactory psychometric properties (α = .82). Regression analysis indicated that persistent thinking about COVID-19 was associated with increased coronavirus anxiety and negative trauma effects. In addition, anxiety served as a partial mediator in the link between persistent thinking about COVID-19 and negative trauma effects. Conclusions. The data obtained suggest that persistent thinking about the pandemic may be dysfunctional for mental health during the spread of the infectious disease.

Sign in / Sign up

Export Citation Format

Share Document